Alnylam reports encouraging pre-clinical results with ALN-HTT program
The findings were the result of research partnership between Alnylam and Medtronic and supported by CHDI. The results demonstrated that a small interfering RNA (siRNA) targeting huntingtin gene,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.